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Abstract 
BACKGROUND: Except bone marrow, people have collected mesenchymal stem cells (MSCs) from placenta tissue, cord blood 
muscle tissue and adipose tissue.  
OBJECTIVE: To compare the difference in biological characteristics and immunoloregulation of rat adipose-derived MSCs 
(ADSCs) and bone marrow MSCs (BMSCs).  
METHODS: ADSCs and BMSCs were obtained respectively from adipose and bone marrow of BN rats. ADSCs and BMSCs 
were isolated and purified in vitro to determine cell morphology, surface marker, growth kinetics and differentiation potential. 
Immunoloregulation of ADSCs and BMSCs was compared in mixed lymphocyte response 
RESULTS AND CONCLUSION: Morphology was similar between ADSCs and BMSCs under an optical microscope and 
transmission electron microscope. ADSCs and BMSCs at passage 3 highly expressed CD29 and CD90, weakly expressed CD34, 
CD45 and CD11b. The proliferation speed of ADSCs at passages 3, 4 and 5 was obviously faster than BMSCs. Both ADSCs and 
BMSCs possessed low immunogenicity, could suppress allogenic antigen-induced T lymphocyte proliferation. Moreover, this 
inhibitory effect was positively associated with cell number. There were no significant differences in inhibitory effects of an equal 
volume of ADSCs and BMSCs. Results verified that ADSCs had the same low immunogenicity and immunoloregulation as 
BMSCs. 
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析，各组间两两比较采用LSD-t 检验，P < 0.05表示差
异有显著性意义。 
 
2  结果 
 












































































a: Primary ADMSCs b: Passage 3 ADMSCs 
c: Passage BMSCs d: Passage 3 BMSCs 
Figure 1  Morphology of adipose-derived mesenchymal stem 
cells (ADSCs) and bone marrow mesenchymal stem 
cells (BMSCs) under an optical microscope (×40) 
图 1  光镜观察(ADSCs)和 BMSCs 形态 (×40) 
a: Passage 3 ADSCs 
b: Passage 3 BMSCs 
Figure 2  Morphology of adipose-derived mesenchymal stem 
cells (ADSCs) and bone marrow mesenchymal stem 
cells (BMSCs) under an electron microscope  
(×5 000) 
图 2  电镜观察(ADSCs)和 BMSCs 结构(×5 000) 
Figure 3  Surface phenotype of adipose-derived mesenchymal 
stem cells (ADSCs) and bone marrow mesenchymal 
stem cells (BMSCs) 




































































































著性意义(P > 0.05)，见图7。 
Figure 4  Growth curve of adipose-derived mesenchymal stem 
cells (ADSCs) and bone marrow mesenchymal stem 
cells (BMSCs) 
图 4  ADSCs 和 BMSCs 生长曲线 
Figure 5  Osteoblast induction and adipocyte induction of 
adipose-derived mesenchymal stem cells (ADSCs) 
and bone marrow mesenchymal stem cells (BMSCs)










Figure 6  Adipose-derived mesenchymal stem cells 
(ADMSCs) and bone marrow mesenchymal stem 
cells (BSCs) failed to elicit a response from T lym-
phoytes, as confirmed by one-way mixed leukocyte 
reaction 
图 6  One-way MLR  ADSCs、BMSCs 未刺激异基因 T 淋
巴细胞增殖 


















a, c: Control group; b: Oilred O staining; d: Von Kossa staining; e, g: 
Control group; f: Oil O staining; h: Von kossa staining 
 
杨中萌，等.大鼠脂肪和骨髓来源间充质干细胞的生物学特性比较 









































































对 BMSCs 的 研 究 表 明 ， 抗 原 递 呈 细 胞
(antigen-presenting cells ,APC)在介导这种作用中扮演
着重要角色[15]，而是否产生调节性T细胞(regulatory T 
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Figure 7  Detection of immunosuppression function of adi-
pose-derived mesenchymal stem cells (ADSCs) and 
bone marrow mesenchymal stem cells (BMSCs) us-
ing two-way mixed leukocyte reaction ( “a” shows 
significant inhibitory effects, P < 0.05) 
图 7  Two-way MLR 检测 ADSCs、BMSCs 免疫抑制功能(a
表示有明显抑制作用，P < 0.05) 
Control 
group 
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网站点击更多 
美国研究人员宣布创造了世界首例由人造基因控制的细胞。科学家克雷格·文特尔表示，他们合成了全新
的基因组，将其植入一个内部被掏空遗传物质的单细胞细菌（山羊支原体），使这个受体细菌“起死回生”，
并开始在实验室的培养皿中繁殖。消息一出，有人喝彩，甚至称“世界首例人造生命诞生”；也有人担忧，
认为这无异于“打开潘多拉魔盒”，会引起生物伦理、生物安全等问题。 人造生命离我们还有多远？ 
http://cn.zglckf.com/Html/2010_06_08/2
_65650_2010_06_08_117756.html 
美国私立科研机构克雷格·文特尔研究所研究人员报告，他们培育出第一个由人工合成基因组控制的细胞，
从而向人造生命形式迈出了关键一步。人造生命相关技术的应用前景固然广阔，但其双刃剑效应绝不可忽
视。 
http://cn.zglckf.com/Html/2010_06_08/2
_65650_2010_06_08_117762.html 
世界首个“人造生命”在美国诞生，现在人类的能力已经拓展到可以“操纵”自然界。不过这一科技突破
也引来不少诟病，批评人士说人类怎能堪当“造物主”之职，美国总统奥巴马也下令举行听证会，讨论这
一问题。 
http://cn.zglckf.com/Html/2010_06_08/2
_65650_2010_06_08_117766.html 
